MD PhD MSc General Partner, LSAN/Azimuth Ventures, USA
MD PhD MSc General Partner, LSAN/Azimuth Ventures, USA
Milena brings a unique perspective of a clinician and academic researcher enriched by the industry and investment experience.
Over 25 years of her career, Dr. Adamian split time equally between leadership and investments roles, including Boston Scientific Corporation (NYSE: BSC), Lehman Brothers, Easton Capital Partners, Azimuth Ventures, and Owlet Baby Care.
Azimuth Ventures is an early stage fund focused on investments in Technology-Enabled Healthcare Solutions, Medical Devices, Medical IoT, and Bioinformatics.
Azimuth Ventures originated from the Life Sciences Angel Network (LSAN), where in addition to leading seed investment in portfolio companies, I single-handedly organized and ran two annual conferences for investors focused on medical devices and healthcare technology.
Milena’s past and present investments and Board involvements include Xoft (now NYSE: ICAD), Cardiovascular Systems (now NYSE: CSII), Forge Medical, Comprehend Systems, Common Sensing, BioTrace Medical, AvhanaHealth, ZappRX, Wellframe, Owlet Baby Care, Stasis Labs.
Milena Adamian was named to the TechWeek100 2014 list of Leaders in NYC with significant impact on business and technology, Women of Influence Honoree 2015 by New York Business Journal, and Woman of Impact 2017 by Impactmania.
Dr. Adamian is a member of the American College of Cardiology, she authored and co-authored 29 scientific peer-reviewed manuscripts.